EW
PODD icon

Evoke Wealth’s Insulet PODD Stock Holding History

Evoke Wealth’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,212
Closed -$254K – 483
2026
Q1 		$254K Buy
+1,212
New +$305K ﹤0.01% 592

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Evoke Wealth's PODD Position: Q2 2026 in Review

Evoke Wealth sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,212 shares — an estimated $254K sold.

Evoke Wealth first reported a position in PODD in Q1 2026 and held it in 1 quarter. The position peaked at $254K in Q1 2026. 726 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Evoke Wealth reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 1,212 Insulet shares in Q2 2026, an estimated $254K.
  • Evoke Wealth first reported a position in Insulet in Q1 2026 and held it in 1 quarter.
  • Evoke Wealth's Insulet position peaked at $254K in Q1 2026.
  • 726 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.